Thiakis
About:
Thiakis develop novel analogues of naturally occurring hormones for the treatment of obesity and co-morbidities.
Top Investors: Novo Ventures, Advent Venture Partners
Description:
Thiakis Limited with a focus on developing novel medicines for the treatment of obesity and co-morbidities based on original research conducted by Professor Steve Bloom and his colleagues at Imperial College London.
Total Funding Amount:
10M GBP
Headquarters Location:
London, England, United Kingdom
Founded Date:
2004-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2006-08-21
IPO Status:
Private
Industries:
© 2025 bioDAO.ai